New Jersey’s adult-use marijuana legalization law explicitly precludes employers from taking any adverse actions against workers “simply for testing positive for cannabinoid metabolites, or for using cannabis, so long as it is not used during the workday and the employee is not intoxicated or impaired at work.”
“These results have significant policy implications, particularly with respect to the use of traditional workplace drug testing. It is high-time to abandon these discriminatory methods in favor of performance testing and fit-for-duty testing, which employ measures to assess whether someone is currently under the influence, whether it be from marijuana on anything else.”
“We conclude from our meta-analysis that … oral fluid tests should not be considered a valid indicator of [cannabis-induced] impairment.”
Consistent with prior studies, investigators reported “no difference in workplace injury risk” among those employees who consumed cannabis while away from the job versus abstainers.
“In the largest trial to date involving experienced users smoking cannabis, there was no correlation between THC (and related metabolites/cannabinoids) in blood, OF [oral fluid], or breath and driving performance. … The complete lack of a relationship between the concentration of the centrally active component of cannabis in blood, OF, and breath is strong evidence against the use of per se laws for cannabis.”
Standard roadside field sobriety tests (FST) are not reliable indicators of marijuana-induced impairment, according to a ruling by the Massachusetts Supreme Court. Attorneys Steven Epstein and Marvin Cable filed an amicus curiae brief in the case on behalf of national NORML.
The mainstream media is abuzz about My Canary — the first-ever NORML-endorsed mobile app that quickly and accurately measures one’s personal performance to determine whether or not he/she may be under the influence of marijuana.
My Canary features four distinct mental and physical performance tests, designed to evaluate baseline performance, and then to compare subjects’ behavior against this established baseline.
For over 45 years NORML has been at the center of national efforts to legalize responsible use of marijuana by adults. But missing from these efforts was an accurate way to measure impairment. Today we’re happy to announce such a way exists and it’s called Canary.